Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.

<h4>Objectives</h4>Neutrophil gelatinase-associated lipocalin (NGAL) and liver-type fatty acid binding protein (L-FABP) are emerging as excellent biomarkers in the urine and plasma for the early prediction of acute and chronic kidney injury. The aims of this prospective study were to det...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kuei-Mei Chou, Chin-Chan Lee, Chih-Huang Chen, Chiao-Yin Sun
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ddc127238c274284887f25013cf07fea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ddc127238c274284887f25013cf07fea
record_format dspace
spelling oai:doaj.org-article:ddc127238c274284887f25013cf07fea2021-11-18T08:00:33ZClinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.1932-620310.1371/journal.pone.0054863https://doaj.org/article/ddc127238c274284887f25013cf07fea2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23349979/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objectives</h4>Neutrophil gelatinase-associated lipocalin (NGAL) and liver-type fatty acid binding protein (L-FABP) are emerging as excellent biomarkers in the urine and plasma for the early prediction of acute and chronic kidney injury. The aims of this prospective study were to determine the role of albuminuria, and that of serum and urine levels of NGAL and L-FABP as predictors of a decline in the glomerular filtration rate (GFR) in patients with type 2 diabetes.<h4>Methods</h4>A longitudinal cohort study with one hundred forty type 2 diabetic patients was conducted. Serum and urine levels of NGAL and L-FABP, and the urine albumin excretion rate were determined. The correlation between the kidney injury biomarkers and rate of GFR decline was analyzed.<h4>Results</h4>The eGFR of study subjects decreased significantly as the study progressed (86.4±31.1 vs. 74.4±27.3 ml/min/1.73 m(2), P<0.001), and the urine albumin excretion rate increased significantly (264.9±1060.3 vs. 557.7±2092.5 mg/day, P = 0.009). The baseline urine albumin excretion rate and serum L-FABP level were significantly correlated with baseline eGFR (P<0.05). The results of regression analysis for the correlations between the rate of eGFR change and the baseline levels of NGAL and L-FABP, and the urine albumin excretion rate showed that only the urine albumin excretion rate was significantly correlated with the rate of eGFR change (standardized coefficients: -0.378; t: -4.298; P<0.001).<h4>Conclusions</h4>Tubular markers, such as NGAL and L-FABP, may not be predictive factors associated with GFR decline in type 2 diabetic patients.Kuei-Mei ChouChin-Chan LeeChih-Huang ChenChiao-Yin SunPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 1, p e54863 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kuei-Mei Chou
Chin-Chan Lee
Chih-Huang Chen
Chiao-Yin Sun
Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
description <h4>Objectives</h4>Neutrophil gelatinase-associated lipocalin (NGAL) and liver-type fatty acid binding protein (L-FABP) are emerging as excellent biomarkers in the urine and plasma for the early prediction of acute and chronic kidney injury. The aims of this prospective study were to determine the role of albuminuria, and that of serum and urine levels of NGAL and L-FABP as predictors of a decline in the glomerular filtration rate (GFR) in patients with type 2 diabetes.<h4>Methods</h4>A longitudinal cohort study with one hundred forty type 2 diabetic patients was conducted. Serum and urine levels of NGAL and L-FABP, and the urine albumin excretion rate were determined. The correlation between the kidney injury biomarkers and rate of GFR decline was analyzed.<h4>Results</h4>The eGFR of study subjects decreased significantly as the study progressed (86.4±31.1 vs. 74.4±27.3 ml/min/1.73 m(2), P<0.001), and the urine albumin excretion rate increased significantly (264.9±1060.3 vs. 557.7±2092.5 mg/day, P = 0.009). The baseline urine albumin excretion rate and serum L-FABP level were significantly correlated with baseline eGFR (P<0.05). The results of regression analysis for the correlations between the rate of eGFR change and the baseline levels of NGAL and L-FABP, and the urine albumin excretion rate showed that only the urine albumin excretion rate was significantly correlated with the rate of eGFR change (standardized coefficients: -0.378; t: -4.298; P<0.001).<h4>Conclusions</h4>Tubular markers, such as NGAL and L-FABP, may not be predictive factors associated with GFR decline in type 2 diabetic patients.
format article
author Kuei-Mei Chou
Chin-Chan Lee
Chih-Huang Chen
Chiao-Yin Sun
author_facet Kuei-Mei Chou
Chin-Chan Lee
Chih-Huang Chen
Chiao-Yin Sun
author_sort Kuei-Mei Chou
title Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
title_short Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
title_full Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
title_fullStr Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
title_full_unstemmed Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
title_sort clinical value of ngal, l-fabp and albuminuria in predicting gfr decline in type 2 diabetes mellitus patients.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/ddc127238c274284887f25013cf07fea
work_keys_str_mv AT kueimeichou clinicalvalueofngallfabpandalbuminuriainpredictinggfrdeclineintype2diabetesmellituspatients
AT chinchanlee clinicalvalueofngallfabpandalbuminuriainpredictinggfrdeclineintype2diabetesmellituspatients
AT chihhuangchen clinicalvalueofngallfabpandalbuminuriainpredictinggfrdeclineintype2diabetesmellituspatients
AT chiaoyinsun clinicalvalueofngallfabpandalbuminuriainpredictinggfrdeclineintype2diabetesmellituspatients
_version_ 1718422699569577984